Skip to main content
. Author manuscript; available in PMC: 2012 Sep 11.
Published in final edited form as: Oncogene. 2003 Feb 27;22(8):1243–1246. doi: 10.1038/sj.onc.1206192

Table 2.

Correlation between LOH on chromosome 12p and Kras2 activation in nonsmall cell lung cancer

Tumor type Patient number Kras2 mutation Frequency of LOH on chromosome 12p Tumors with Kras2 mutations and LOH
Adenocarcinoma 22 9/22 (40.9%) 10/22 (45.5%) 9/10 (90.0%)
Large cell carcinoma 8 3/8 (37.5%) 4/8 (50.0%) 3/4 (75.0%)